2019
DOI: 10.1101/618637
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Modulating pathogenesis with Mobile-CRISPRi

Abstract: Pathogens express a set of proteins required for establishing and maintaining an infection, termed virulence life-style genes (VLGs). Due to their outsized importance in pathogenesis, VLG products are attractive targets for the next generation of antimicrobials.However, precise manipulation of VLG expression in the context of infection is technically challenging, limiting our ability to understand the roles of VLGs in pathogenesis and accordingly design effective inhibitors. We previously developed a suite of … Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 49 publications
0
1
0
Order By: Relevance
“…Both systems were demonstrated to be functional for repression of genes encoding fluorescent proteins, and Kim et al (2020) also employed CRISPRi for metabolic engineering via gene repression by depleting the GlpR regulator to enhance the glycerol-dependent synthesis of mevalonate. Other examples on the development of CRISPRi systems have been reported for P. aeruginosa (Peters et al, 2019;Qu et al, 2019) and P. fluorescens (Noirot-Gros et al, 2019). While the CRISPRi toolbox for Pseudomonas species offers alternatives depending on the intended application (ranging from fundamental studies to simple metabolic engineering manipulations), the techniques applied so far are afflicted by either leaky expression of the components or limited ability to titrate repression levelsthus restricting the applicability of the tool in complex engineering approaches.…”
Section: Introductionmentioning
confidence: 99%
“…Both systems were demonstrated to be functional for repression of genes encoding fluorescent proteins, and Kim et al (2020) also employed CRISPRi for metabolic engineering via gene repression by depleting the GlpR regulator to enhance the glycerol-dependent synthesis of mevalonate. Other examples on the development of CRISPRi systems have been reported for P. aeruginosa (Peters et al, 2019;Qu et al, 2019) and P. fluorescens (Noirot-Gros et al, 2019). While the CRISPRi toolbox for Pseudomonas species offers alternatives depending on the intended application (ranging from fundamental studies to simple metabolic engineering manipulations), the techniques applied so far are afflicted by either leaky expression of the components or limited ability to titrate repression levelsthus restricting the applicability of the tool in complex engineering approaches.…”
Section: Introductionmentioning
confidence: 99%